Pulmatrix, Inc. SEC filings PULM
Pulmatrix, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 24, 2013. Its latest annual report, Form ARS, was filed on Oct 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Oct 30, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 27, 2026 | Oct 26, 2026 |
| 424B3 | Prospectus | Oct 26, 2026 | — |
| EFFECT | Filing | Oct 22, 2026 | — |
| 425 | Filing | Oct 22, 2026 | — |
| 425 | Filing | Oct 13, 2026 | — |
| 424B3 | Prospectus | Oct 7, 2026 | — |
| DEFA14A | Additional proxy material | Oct 7, 2026 | — |
| ARS | Annual report to shareholders | Oct 5, 2026 | Dec 31, 2025 |
| S-3/A | Filing | Oct 5, 2026 | — |
| EFFECT | Filing | Sep 25, 2026 | — |
| 424B3 | Prospectus | Sep 25, 2026 | — |
| DEFM14A | Filing | Sep 25, 2026 | — |
| S-4/A | Filing | Sep 23, 2026 | — |
| 425 | Filing | Sep 22, 2026 | — |
| S-4/A | Filing | Sep 17, 2026 | — |
| S-4/A | Filing | Sep 4, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| S-3/A | Filing | Aug 7, 2026 | — |
| S-4/A | Filing | Aug 3, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 9, 2026 | — |
| 10-K/A | Amended annual report | Jun 16, 2026 | Dec 31, 2025 |
| 425 | Filing | Jun 5, 2026 | — |
| S-3 | Shelf registration | Jun 4, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| DRS | Filing | May 14, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 22, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 21, 2026 | Apr 16, 2026 |
| D | Filing | Apr 15, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 27, 2026 | Mar 26, 2026 |
| 425 | Filing | Mar 26, 2026 | — |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Mar 2, 2026 | Feb 28, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 17, 2025 |
| 10-Q | Quarterly report | Oct 16, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 16, 2025 | Oct 16, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 425 | Filing | Jun 16, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Acquisition or sale of assets
|
May 15, 2025 | May 15, 2025 |
| EFFECT | Filing | May 9, 2025 | — |
| 424B3 | Prospectus | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| S-4/A | Filing | May 7, 2025 | — |
| S-4/A | Filing | Apr 17, 2025 | — |
| CORRESP | Letter to the SEC | Apr 17, 2025 | — |
| 8-K |
Current report
Material agreement, Change in control
|
Apr 10, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 8, 2025 | Apr 4, 2025 |
| 10-K | Annual report | Mar 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2025 | Mar 21, 2025 |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 14, 2025 | Feb 11, 2025 |
| 425 | Filing | Jan 22, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| ARS | Annual report to shareholders | Nov 8, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Nov 8, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K | Current report | Oct 8, 2024 | Oct 3, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2024 | Jul 15, 2024 |
| EFFECT | Filing | May 30, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 29, 2024 | May 28, 2024 |
| CORRESP | Letter to the SEC | May 28, 2024 | — |
| UPLOAD | Letter from the SEC | May 23, 2024 | — |
| S-3 | Shelf registration | May 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 424B3 | Prospectus | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 2, 2024 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 13, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 11, 2023 | Jul 11, 2023 |
| ARS | Annual report to shareholders | Jun 2, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Jun 2, 2023 | Jun 2, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2023 | Feb 3, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 25, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2023 | Jan 11, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2022 | Sep 26, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 8, 2022 |
| 424B3 | Prospectus | Aug 9, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 15, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 29, 2022 | Apr 28, 2022 |
| 3 | Initial insider ownership | Apr 19, 2022 | Apr 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 14, 2022 |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 29, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Other events
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Other events
|
Mar 4, 2022 | Mar 1, 2022 |
| 4 | Insider transaction | Mar 3, 2022 | Mar 1, 2022 |
| 3 | Initial insider ownership | Mar 3, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Other events
|
Feb 15, 2022 | Feb 15, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Feb 11, 2022 | Feb 10, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| DEFA14A | Additional proxy material | Feb 1, 2022 | — |
| 4 | Insider transaction | Jan 31, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 31, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 31, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 28, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 28, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 28, 2022 | Jan 27, 2022 |
| 4 | Insider transaction | Jan 28, 2022 | Jan 27, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 5, 2022 | — |
| DEFA14A | Additional proxy material | Dec 30, 2021 | — |
| DEF 14A | Proxy statement | Dec 30, 2021 | Dec 30, 2021 |
| PRE 14A | Preliminary proxy statement | Dec 20, 2021 | Dec 20, 2021 |
| DEFA14A | Additional proxy material | Dec 17, 2021 | — |
| 8-K |
Current report
Other events
|
Dec 17, 2021 | Dec 17, 2021 |
| 424B5 | Prospectus supplement | Dec 17, 2021 | — |
| DEFA14A | Additional proxy material | Dec 17, 2021 | — |
| 8-K/A |
Amended current report
Material agreement, Bylaw or fiscal year change
|
Dec 17, 2021 | Dec 15, 2021 |
| DEFA14A | Additional proxy material | Dec 15, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Dec 15, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2021 | Dec 7, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 9, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Listing notice
|
Aug 23, 2021 | Aug 17, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 4 | Insider transaction | Jul 28, 2021 | Jul 26, 2021 |
| 3 | Initial insider ownership | Jul 28, 2021 | Jul 26, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 27, 2021 | Jul 23, 2021 |
| D | Filing | Jul 20, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2021 | Jun 16, 2021 |
| EFFECT | Filing | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 7, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2021 | — |
| S-3 | Shelf registration | May 26, 2021 | — |
| 10-K/A | Amended annual report | May 14, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Other events
|
May 10, 2021 | May 10, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2021 | Apr 29, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| 8-K/A |
Amended current report
Other events
|
Apr 13, 2021 | Apr 6, 2021 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure, Other events
|
Apr 12, 2021 | Apr 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2021 | Apr 2, 2021 |
| 10-K/A | Amended annual report | Mar 26, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 23, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2021 | Mar 4, 2021 |
| SC 13D | Ownership over 5% (active) | Feb 25, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 24, 2021 | — |
| D | Filing | Feb 23, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Feb 16, 2021 | Feb 11, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| 4 | Insider transaction | Feb 1, 2021 | Jan 28, 2021 |
| 4 | Insider transaction | Feb 1, 2021 | Jan 28, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PULM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Framingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1574235
- Former names
- Ruthigen, Inc. (until Jun 16, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.